Personalized Treatments: Is That Possible and What Can Data Science Tell Us?
Listen now
Description
Today we discuss the most important element of our lives: our health. We do so by diving into personalized medicine, or more specifically, personalized (N-of-1) trials  – clinical trials in which a single patient is the entire trial. For this episode, we invited two editors of Harvard Data Science Review’s special issue on N-of-1 trials and data science to help us examine all aspects of these clinical trials designed for a population of one person. Our guests: Dr. Karina Davidson, Senior Vice President of Research and Dean of Academic Affairs at Northwell Health Ken Cheung, Professor of Biostatistics at Mailman School of Public Health at Columbia University
More Episodes
As the U.S. approaches another presidential election, many of us are contemplating our beliefs, staying informed about election news, and at times, questioning the integrity of the voting polls. This month we delve into the upcoming House, Senate, and presidential elections with the help of two...
Published 03/28/24
The financial industry has a rich history of leveraging data for predictive purposes. From hedge funds employing regression analysis to fine-tune portfolios to individuals utilizing summary statistics in pursuit of the next groundbreaking startup, data has been a cornerstone of investment...
Published 02/23/24